MedPath

Cebix Incorporated

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Phase 2
Completed
Conditions
Diabetic Peripheral Neuropathy
Interventions
First Posted Date
2012-09-07
Last Posted Date
2015-01-30
Lead Sponsor
Cebix Incorporated
Target Recruit Count
250
Registration Number
NCT01681290

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

Phase 1
Completed
Conditions
Peripheral Diabetic Neuropathy
Type 1 Diabetes
Diabetes Mellitus
Interventions
Drug: Placebo
First Posted Date
2011-02-10
Last Posted Date
2013-03-01
Lead Sponsor
Cebix Incorporated
Target Recruit Count
72
Registration Number
NCT01293461

News

No news found
© Copyright 2025. All Rights Reserved by MedPath